Prescription drug network sales need to be real -name system!This new rules will be implemented from December

Recently, the General Administration of Market Supervision issued the "Measures for the Supervision and Administration of Drug Network Sales" (hereinafter referred to as the "Measures"), which will be implemented from December 1, 2022.

The "Measures" focus on ensuring the quality and safety of drugs, convenient for the masses, and the design of the system of drug network sales supervision and management.

In recent years, with the rapid development of my country's e -commerce, online shopping has become a normal consumption method, and drug network sales activities have become increasingly active. In order to improve the level of medical and health modernization services, the State Council has introduced a series of policies to require innovative service models to improve the "Internet+" pharmaceutical supply guarantee services, and meet the people's growing medical and health needs.

The promulgation of the Measures will further standardize the drug network sales behavior, ensure the quality and safety of drugs for online sales, ensure that the people's medication can be available, and effectively maintain the safety and physical health of the people.

1

Prescription drug network sales implemented real -name system

Blood products cannot be sold online

For controversial prescription drug network sales issues, the "Measures" put forward the following requirements-

◎ Pharmaceutical network retail enterprises shall not violate regulations to give individuals and category A non -prescription drugs to individuals by buying drugs and giving medicines.

◎ Those who sell prescriptions to individual sales through the Internet shall ensure that the source of the prescription should be true and reliable, and the real -name system should be implemented.

◎ Drug network retail companies engaged in prescription drug sales shall highlight risk warning information such as "prescription drugs must be purchased and used under the guidance of pharmacists under the guidance of pharmacists" under each drug display page.

◎ Drug network retail enterprises shall distinguish the prescription drugs from non -prescription drugs, and significantly indicate prescription drugs and non -prescription drugs on the related webpages.

◎ Pharmaceutical network retail enterprises shall not directly display information such as prescription drug packaging and labels on the homepage and homepage of pharmaceutical networks. Before the prescription review, no information such as the manual shall be displayed, and the relevant services of the prescription medicine purchase shall not be provided.

In addition, the "Measures" stipulates that vaccine, blood products, anesthesia drugs, psychotropic drugs, medical use toxic drugs, radioactive drugs, pharmaceuticals and vulnerable chemicals and other countries shall not be sold on the Internet. The Organization of the Drug Administration is formulated.

2

Pharmaceutical network sales enterprise

Must be offline physical pharmaceutical companies

The "Measures" requires that pharmaceutical network sales companies must be offline physical pharmaceutical companies to strengthen drug quality and safety guarantee and consumer rights protection.

The "Measures" stipulates that those engaged in drug network sales should be a pharmaceutical listing license holder or drug operating enterprise with drug safety capabilities to ensure the safety capacity of online sales. That is, the holder of the pharmaceutical listing license or the business enterprise obtaining a drug business license can develop the drug network sales business.

3

Third-party platform

Drug quality and safety management institutions should be set up

As a "platform manager", the third -party platform plays a unique role in the drug network sales activities. It is a key part of the healthy development of drug network sales. The main body of the platform and strengthening the internal management of the platform is essential for the standardization of pharmaceutical network sales activities and the orderly development of the market.

The "Measures" made a series of regulations on the management of third -party platforms--

■ The platform shall establish a pharmaceutical quality and safety management institution, establish and implement management systems such as drug quality and safety, and equip pharmaceutical technical personnel to record the provincial pharmaceutical supervision and management department in accordance with regulations.

■ Inspection should be strengthened to manage the drug information display, prescription review, pharmaceutical sales and distribution of pharmaceutical network sales enterprises on the platform, and urge them to strictly fulfill their legal obligations.

■ Those who do not have serious illegal acts such as qualified sales drugs should immediately stop providing online trading platform services and stop displaying drug -related information.

---

Edit | Zhou Yanmei Responsible | Zhang Xiuli

Comprehensive source | The official website of the State Administration of Market Supervision and Administration

Produced by Guangdong Health Online All -Media Team

- END -